The Column
Recent developments in the miniaturization of gas chromatography–mass spectrometry (GC–MS) instrumentation are making the technique available for field-based investigations, offering a simple, onsite identification of drug substances. This article describes the identification of sixteen drugs compounds in less than 10 min using portable gas chromatograph-toroidal ion trap mass spectrometry combined with a coiled-wire-filament (CWF) sampling injector to provide an effective tool for the rapid analysis of illicit drug substances.
Photo Credit: Kaesler Media/Shutterstock.com
Ramon Soto Alvarez, Ashley Thornock, Serena Michalsky, and David C. Collins, Chemistry Department, Brigham Young University – Idaho, Rexburg, Idaho, USA
Recent developments in the miniaturization of gas chromatography–mass spectrometry (GC–MS) instrumentation are making the technique available for field-based investigations, offering a simple, onsite identification of drug substances. This article describes the identification of sixteen drugs compounds in less than 10 min using portable gas chromatograph-toroidal ion trap mass spectrometry combined with a coiled-wire-filament (CWF) sampling injector to provide an effective tool for the rapid analysis of illicit drug substances.
The misuse of drug substances has created an urgent need to rapidly determine the type of chemical compounds present in the field. Gas chromatography–mass spectrometry (GC–MS) has routinely been used by scientists in the laboratory to characterize the presence of pain medication compounds. Unfortunately, the confirmation process can be extremely slow and time-consuming because the sample must be taken back to the laboratory to perform the analysis. As a result of this limitation, a rapid, on-site solution to the identification and characterization of these compounds is desirable. This study will describe an approach for performing this analysis, using a compact, portable GC–MS system for use by nonspecialist operators in the field.
Methods
The portable GC–MS technology used in this investigation is described in the open literature (1,2). When used in conjunction with an extensive NIST database and custom-built target compound libraries, unknown peaks can be positively identified by nonexperienced personnel in the field (3,4).
Sample Collection: For different sample types, a small, battery-operated, sampling accessory (SPS-3, PerkinElmer Inc.) was available (5), which requires the use of a needle trap (NT) to transfer the analytes to the GC–MS system. Based on the samples being studied, the choice of sampling strategies include:
For this study, a CWF sampling accessory was used. A method for the separation and identification of sixteen painkilling drugs using this approach was performed.
Sample Preparation and Analysis: Methanol solutions (1.0 mg/mL) of standard drug substances (methamphetamine, tapentadiol, methadone, cannabidiol, hydrocodone, morphine, hydromorphone, codeine, diazepam, oxycodone, cannabinol, oxymorphone, fentanyl, clonazepam, alprazolam, and buprenorphine) were used (Cerilliant) for the investigation. A single mixture of all sixteen drugs was prepared (60 μg/mL). Prior to injection, and to eliminate backflash of the methanol within the injector of the gas chromatography toroidal mass spectrometer (GC–TMS) system, the sample was first added to a novel deactivated stainless steel CWF (PerkinElmer) with subsequent evaporation of methanol at room temperature and pressure under a fan (1–5 min). Upon introduction of the CWF into the injector of the GC–TMS system, the compounds were thermally desorbed.
The sample was applied to the CWF by the following two methods:
Direct application using a syringe allowed for known and variable (0.5–10 μL) sample volumes to be applied consistently to the CWF. Larger volumes (5–10 μL) required extended drying time (3–5 min). Dipping resulted in approximately 0.5 μL of sample coating the coil; drying time was consistently 1 min. Once dry, the CWF containing the sample was introduced into the injection port of the GC–TMS system and the coil exposed for 20 s. The gas chromatographic separation conditions and mass spectrometer parameters used for the analysis are detailed below.
Gas Chromatographic Separation Conditions: Sample delivery: coiled wire filament injection; injection type: splitless; split injection times: 50:1 split on: 20 s, 50:1 split off: 60 s; injector temperature: 275 °C; column: 5 m × 0.1 mm, 4-µm MXTâ5 lowâpolarity phase diphenyl dimethyl polysiloxane (Restek); initial temperature and hold time: 40 °C for 20 s; temperature ramp rate: 1.25 °C/s; final temperature and hold time: 300 °C for 147 s; total analysis time: 375 s.
Mass Spectrometer Operating Conditions: Mass spectrometer: Toroidal Ion Trap (PerkinElmer); ionization source: electron impact; MS operating temperature: 160 °C; mass range: 45–500 amu; resolution: <0.5 m/z at 300 amu; MS scan rate: 10–15 scans/s; detector: Electron Multiplier (DeTech).
A custom user-defined compound library was created with individual drug standards to determine drug retention times and mass fragmentation patterns. The library was subsequently used to identify the mixture of sixteen target analytes employing an on-board deconvolution algorithm for the drugs that coeluted.
Results and Discussion
Figure 1 shows a chromatogram of all sixteen drugs when direct application of 5 μL of a drug mixture (60-μg/mL of each drug) was applied to the CWF prior to injection. Twelve of the sixteen drugs had unique retention times and 10 could be separated with baseline resolution.
Although two pairs of drugs (hydrocodone–morphine and cannabinol–hydromorphone) coelute (Figure 2), their mass spectra are significantly different, which can then be deconvoluted and identified using the on-board algorithm, as shown in Figure 3. Under ideal conditions, the whole identification and confirmation process requires approximately 8–10 min.
All sixteen drugs were simultaneously identified with a direct application of 5 μL (~300 ng/drug) to the CWF, as seen in Figure 1. However, this was not possible with dipping the coil in the sample. This is exemplified in Figure 4, which shows a chromatogram of all sixteen drugs when dipping the CWF into a drug mixture (60 μg/mL of each drug).
After separation and deconvolution, only 10–12 of the sixteen drugs could be identified. With this lower amount of sample (~30 ng/drug), signal intensity for fentanyl (~7000), and many other compounds, is approximately 1/10th the signal intensity in Figure 1 (70,000). In fact, the later eluting compounds (clonazepam, alprazolam, and buprenorphine) cannot be seen or identified. In addition, at least one of the lower-intensity compounds (morphine, hydromorphone, and oxymorphone) is unidentified after separation and deconvolution. On the other hand, the dipping technique is much simpler and requires less time, but also requires approximately 10× the concentration of drugs for an equivalent signal. As previously mentioned, it is estimated that ~0.5 μL of the sample is collected on the CWF during dipping.
Conclusion
This study has shown that the preparation, separation, and identification of sixteen common drug substances is possible in the field using a combination of a coiled wire filament sampling device coupled with a gas chromatograph–toroidal ion trap mass spectrometer in under 10 min. This portable, field-based approach has opened up new possibilities for on-site analysis using nonexperienced operators, without having to take samples back to the laboratory for confirmation of the chemical compounds.
References
Ramon Soto Alvarez, Ashley Thornock, and Serena Michalsky are undergraduate students at Brigham Young University, Idaho, USA, who are gaining research experience investigating separation science techniques. Ramon and Ashley are chemistry majors, and Serena is a biochemistry major, who plans to attend medical school.
David C. Collins received a B.S. degree in chemistry at Weber State University (Ogden, Utah, USA) in 1997, and a Ph.D. in analytical chemistry at Brigham Young University (Provo, Utah) in 2001. He has taught both forensic science and chemistry at Weber State University, Colorado State University – Pueblo, and Brigham Young University – Idaho, and has received several teaching awards. In addition, David has written many peer-reviewed articles in separation science and is the author of the forensic science laboratory manual Investigating Chemistry in the Laboratory.
E-mail:collinsd@byui.eduWebsite:www.byui.edu/chemistry/
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.